Process for the production of a hybrid structure consisting of coupled silk fibroin microfibers and nanofibers, hybrid structure thus obtained and its use as implantable medical device
AssigneeSilk Biomaterials S.R.L.
InventorAntonio Alessandrino
Life of this patent
Estimating the term…
Abstract
A method is described for the production of hybrid structures formed by the coupling of nanofibrous parts and microfibrous parts made with silk fibroin, possibly hierarchically organized into complex structures comprising more than two of said parts; these hybrid structures are used as implantable biomedical devices with tailored biological, geometrical and structural features, such that they can be adapted to different application requirements in the field of regenerative medicine.
Claims12
An implantable medical device comprising:
- a hybrid structure comprising coupled microfibers and nanofibers of silk fibroin, said hybrid structure obtained according to the process comprising:
- a) preparing of one or more parts made of microfibrous fibroin;
- b) preparing of one or more parts made of nanofibrous fibroin;
- c) treating of said one or more parts of nanofibrous fibroin and of said one or more parts of microfibrous fibroin, separately or after coupling, with a solvent for fibroin and/or with a solution comprising fibroin dissolved in the solvent;
- c′) if in step c) the nanofibrous and microfibrous parts have been treated separately with a solvent for fibroin and/or with a solution comprising fibroin dissolved in a solvent, coupling of said parts;
- d) consolidating the hybrid microfibrous/nanofibrous structure obtained in step c) or in step c′) by thermal treatment at a temperature between 10° C. and 150° C., for a time between 1 minute and 24 hours;
- e) removing the solvent by washing with water or a water-alcohol mixture at a temperature between 10° C. and 100° C., or by evaporation at a temperature between 10° C. and 100° C.,
- wherein the solvent for fibroin or the solvent of the solution comprising fibroin used in step c) is selected from:
- (i) formic acid, 1,1,1,3,3,3-hexafluoro-2-propanol, trifluoroacetic acid, hexafluoroacetone, N-methylmorpholine N-oxide, ionic liquids, and mixtures thereof, wherein said solvents are pure or in mixture with water;
- (ii) calcium chloride-ethanol-water mixtures, calcium nitrate-methanol-water mixtures, aqueous solutions of lithium salts and;
- (iii) mixtures among the solvents of (i) and (ii).
Implantable medical device comprising a hybrid structure comprising coupled microfibers and nanofibers of silk fibroin, having a mean separation force, measured according to the method defined in standard UNI EN ISO 13937-2:2000, of 53±11 cN when the microfiber part is in the form of crepe and of 21±9 cN when the microfiber part is in the form of organza.
Dependencies are inferred from the claim text.